Herald Sun | Alzheimer's breakthrough: Melbourne patients first in world to access drug Herald Sun Under current treatments, moderate-range Alzheimer's patients typically drop about two points a year on the 30-point cognitive test used to measure dementia. However, those on the Anavex trial actually rose an average of 1.8 points on the cognitive ... |